ASX:KBC Keybridge Capital (KBC) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free KBC Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield14.08%Price TargetN/A Stock AnalysisStock Analysis Get Keybridge Capital alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Keybridge CapitalJam Development Capital Ltd is engaged in investment in Australian small and medium enterprises.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> KBC Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive KBC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Keybridge Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolASX:KBC CUSIPN/A CIKN/A Webwww.keybridge.com.au Phone61 3 9686 7000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.04 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$2.94 million Net Margins8.00% Pretax MarginN/A Return on Equity25.89% Return on Assets14.41% Debt Debt-to-Equity Ratio1.05 Current Ratio2.33 Quick Ratio3.41 Sales & Book Value Annual Sales$36.74 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.10 per share Price / BookN/AMiscellaneous Outstanding Shares207,340,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.31 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. John Dean Patton B.Ec.CA, F Fin, Non-Executive Chairman & Company SecretaryMr. Nicholas Francis John BoltonCEO, MD & DirectorMs. Janet RobertsonHead of Corporate Support & Marketing of Mariner Financial GroupKey Competitors360 Capital GroupASX:TGP360 Capital Mortgage REITASX:TCF3i GroupOTCMKTS:TGOPF3i GroupOTCMKTS:TGOPYAB Industrivärden (publ)OTCMKTS:IDDTFView All Competitors KBC Stock Analysis - Frequently Asked Questions Is Keybridge Capital a good dividend stock? Keybridge Capital (ASX:KBC) pays an annual dividend of A$0.01 per share and currently has a dividend yield of 14.08%. KBC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 25.00%. This payout ratio is at a healthy, sustainable level, below 75%. This page (ASX:KBC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keybridge Capital Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
